Amundi Grows Stock Holdings in Omega Healthcare Investors, Inc. $OHI

Amundi grew its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 125.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,298,280 shares of the real estate investment trust’s stock after acquiring an additional 721,611 shares during the period. Amundi owned about 0.44% of Omega Healthcare Investors worth $47,374,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. PNC Financial Services Group Inc. raised its position in Omega Healthcare Investors by 27.7% during the 1st quarter. PNC Financial Services Group Inc. now owns 13,529 shares of the real estate investment trust’s stock valued at $515,000 after purchasing an additional 2,936 shares in the last quarter. Deutsche Bank AG increased its stake in shares of Omega Healthcare Investors by 362.2% during the first quarter. Deutsche Bank AG now owns 1,070,805 shares of the real estate investment trust’s stock valued at $40,776,000 after buying an additional 839,111 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of Omega Healthcare Investors by 9.1% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 194,888 shares of the real estate investment trust’s stock valued at $7,421,000 after acquiring an additional 16,247 shares in the last quarter. Swiss National Bank lifted its stake in Omega Healthcare Investors by 3.1% in the first quarter. Swiss National Bank now owns 523,000 shares of the real estate investment trust’s stock worth $19,916,000 after acquiring an additional 15,900 shares during the period. Finally, Citigroup Inc. grew its holdings in Omega Healthcare Investors by 38.6% during the 1st quarter. Citigroup Inc. now owns 293,449 shares of the real estate investment trust’s stock worth $11,175,000 after acquiring an additional 81,705 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Insider Transactions at Omega Healthcare Investors

In other news, CIO Vikas Gupta acquired 11,500 shares of Omega Healthcare Investors stock in a transaction dated Thursday, November 6th. The stock was purchased at an average cost of $42.97 per share, for a total transaction of $494,155.00. Following the completion of the purchase, the executive directly owned 13,773 shares in the company, valued at $591,825.81. This trade represents a 505.94% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO C Taylor Pickett bought 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The shares were purchased at an average cost of $43.14 per share, with a total value of $862,800.00. Following the acquisition, the chief executive officer directly owned 20,000 shares of the company’s stock, valued at approximately $862,800. This trade represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 1.50% of the stock is currently owned by corporate insiders.

Omega Healthcare Investors Stock Down 1.0%

OHI stock opened at $45.22 on Wednesday. The stock has a market capitalization of $13.36 billion, a PE ratio of 25.26, a price-to-earnings-growth ratio of 2.04 and a beta of 0.56. Omega Healthcare Investors, Inc. has a 52 week low of $35.04 and a 52 week high of $46.36. The company has a quick ratio of 7.11, a current ratio of 7.11 and a debt-to-equity ratio of 0.95. The firm has a 50 day moving average of $42.78 and a 200 day moving average of $40.55.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Thursday, October 30th. The real estate investment trust reported $0.79 EPS for the quarter, topping the consensus estimate of $0.77 by $0.02. Omega Healthcare Investors had a net margin of 46.83% and a return on equity of 10.72%. The business had revenue of $311.59 million during the quarter, compared to the consensus estimate of $262.48 million. During the same period in the previous year, the firm posted $0.71 earnings per share. The business’s revenue for the quarter was up 14.4% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. Sell-side analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Monday, November 3rd were paid a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 5.9%. The ex-dividend date was Monday, November 3rd. Omega Healthcare Investors’s payout ratio is presently 149.72%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. Wells Fargo & Company increased their price objective on shares of Omega Healthcare Investors from $45.00 to $48.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Cantor Fitzgerald began coverage on Omega Healthcare Investors in a research report on Wednesday, October 1st. They set an “overweight” rating and a $50.00 target price on the stock. Citigroup reissued a “buy” rating and issued a $50.00 price target (up from $45.00) on shares of Omega Healthcare Investors in a research report on Wednesday, November 12th. Raymond James Financial restated an “outperform” rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Omega Healthcare Investors in a research note on Wednesday, October 8th. Six equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Omega Healthcare Investors has an average rating of “Moderate Buy” and an average price target of $46.63.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.